KR101885046B1 - 연속 세포 배양에서 목적 폴리펩티드 또는 바이러스를 생산하는 방법 - Google Patents

연속 세포 배양에서 목적 폴리펩티드 또는 바이러스를 생산하는 방법 Download PDF

Info

Publication number
KR101885046B1
KR101885046B1 KR1020177017512A KR20177017512A KR101885046B1 KR 101885046 B1 KR101885046 B1 KR 101885046B1 KR 1020177017512 A KR1020177017512 A KR 1020177017512A KR 20177017512 A KR20177017512 A KR 20177017512A KR 101885046 B1 KR101885046 B1 KR 101885046B1
Authority
KR
South Korea
Prior art keywords
cell
cells
culture
culture system
cell culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020177017512A
Other languages
English (en)
Korean (ko)
Other versions
KR20170077286A (ko
Inventor
레오폴트 그릴베르거
만프레트 라이터
다니엘 플라이샨데를
Original Assignee
박스알타 인코퍼레이티드
박스앨타 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 박스알타 인코퍼레이티드, 박스앨타 게엠베하 filed Critical 박스알타 인코퍼레이티드
Publication of KR20170077286A publication Critical patent/KR20170077286A/ko
Application granted granted Critical
Publication of KR101885046B1 publication Critical patent/KR101885046B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/006Cell injection or fusion devices
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0056Xeno-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/98Xeno-free medium and culture conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/00051Methods of production or purification of viral material
    • C12N2710/00052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24087ADAMTS13 endopeptidase (3.4.24.87)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
KR1020177017512A 2009-07-31 2010-08-02 연속 세포 배양에서 목적 폴리펩티드 또는 바이러스를 생산하는 방법 Active KR101885046B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23031309P 2009-07-31 2009-07-31
US61/230,313 2009-07-31
PCT/EP2010/061191 WO2011012725A1 (en) 2009-07-31 2010-08-02 Method of producing a polypeptide or virus of interest in a continuous cell culture

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020127004996A Division KR101752789B1 (ko) 2009-07-31 2010-08-02 연속 세포 배양에서 목적 폴리펩티드 또는 바이러스를 생산하는 방법

Publications (2)

Publication Number Publication Date
KR20170077286A KR20170077286A (ko) 2017-07-05
KR101885046B1 true KR101885046B1 (ko) 2018-08-02

Family

ID=42668436

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020127004996A Active KR101752789B1 (ko) 2009-07-31 2010-08-02 연속 세포 배양에서 목적 폴리펩티드 또는 바이러스를 생산하는 방법
KR1020177017512A Active KR101885046B1 (ko) 2009-07-31 2010-08-02 연속 세포 배양에서 목적 폴리펩티드 또는 바이러스를 생산하는 방법

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020127004996A Active KR101752789B1 (ko) 2009-07-31 2010-08-02 연속 세포 배양에서 목적 폴리펩티드 또는 바이러스를 생산하는 방법

Country Status (22)

Country Link
US (4) US8580554B2 (enExample)
EP (2) EP2459697B1 (enExample)
JP (2) JP5808742B2 (enExample)
KR (2) KR101752789B1 (enExample)
CN (1) CN102549142B (enExample)
AU (1) AU2010277490B2 (enExample)
BR (1) BR112012002137B8 (enExample)
CA (1) CA2769354A1 (enExample)
CO (1) CO6491119A2 (enExample)
DK (1) DK2459697T3 (enExample)
EA (1) EA022219B1 (enExample)
ES (1) ES2705206T3 (enExample)
HR (1) HRP20182165T1 (enExample)
IN (1) IN2012DN00899A (enExample)
MX (2) MX2012001274A (enExample)
NZ (1) NZ597742A (enExample)
PL (1) PL2459697T3 (enExample)
PT (1) PT2459697T (enExample)
SG (1) SG178176A1 (enExample)
SI (1) SI2459697T1 (enExample)
TR (1) TR201900213T4 (enExample)
WO (1) WO2011012725A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3392271B8 (en) 2010-07-08 2021-06-16 Takeda Pharmaceutical Company Limited Method of producing recombinant adamts13 in cell culture
EP2665806B1 (en) * 2011-01-17 2021-07-28 F. Hoffmann-La Roche AG Separation apparatus
EP2707387B1 (en) 2011-05-13 2019-12-25 Octapharma AG A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii
IL288509B2 (en) 2011-07-01 2023-04-01 Amgen Inc Mammalian cell culture
CN203129697U (zh) 2013-02-05 2013-08-14 客贝利(厦门)休闲用品有限公司 一种帐篷架杆
EP3327119A1 (en) 2011-11-24 2018-05-30 Genethon Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
US9574167B2 (en) 2013-02-15 2017-02-21 Pharyx, Inc. Methods and apparatus for independent control of product and reactant concentrations
IL274646B (en) 2013-03-08 2022-09-01 Genzyme Corp Integrated continuous production of medicinal substances from medical protein
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
DK2976418T3 (da) 2013-03-19 2021-01-11 Cmc Biologics As Fremgangsmåde til fremstilling af et produkt (f.eks. polypeptid) i en kontinuerlig cellekulturfermenteringsproces
CA2920934C (en) * 2013-08-30 2022-12-06 Glaxosmithkline Biologicals S.A. Large scale production of viruses in cell culture
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
AU2015240353A1 (en) 2014-04-01 2016-11-17 Advantech Bioscience Farmaceutica Ltda. Stable Factor VIII formulations with low sugar-glycine
WO2015149144A2 (en) 2014-04-01 2015-10-08 Advantech Bioscience Farmacêutica Ltda. Stabilization of factor viii without calcium as an excipient
WO2015188224A1 (en) * 2014-06-13 2015-12-17 Csl Limited Improved production of recombinant von willebrand factor in a bioreactor
KR20240173213A (ko) 2016-01-26 2024-12-10 베링거 인겔하임 인터내셔날 게엠베하 연결된 관류 대 연속-유동식 교반-탱크 반응기 세포 배양 시스템
KR102414290B1 (ko) * 2016-04-15 2022-06-29 베링거 인겔하임 인터내셔날 게엠베하 세포 보유 장치 및 방법
WO2018115161A1 (en) * 2016-12-21 2018-06-28 F. Hoffmann-La Roche Ag Growth control of eukaryotic cells
IL321253A (en) 2018-05-01 2025-08-01 Amgen Inc Antibodies with a modulated glycan profile
WO2019239780A1 (ja) * 2018-06-15 2019-12-19 富士フイルム株式会社 細胞培養方法、細胞培養装置、及び生産物の製造方法
EP3843869A1 (en) 2018-08-31 2021-07-07 Genzyme Corporation Sterile chromatography resin and use thereof in manufacturing processes
CN113355297A (zh) * 2021-06-23 2021-09-07 吉林冠界生物技术有限公司 一种灌流式培养全悬浮mdck细胞生产重组禽流感病毒的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019512A (en) 1989-03-17 1991-05-28 Baxter International Inc. Spin filter for removing substantially cell-free culture medium from suspension cell culture system
US5626734A (en) 1995-08-18 1997-05-06 University Technologies International, Inc. Filter for perfusion cultures of animal cells and the like
KR100880624B1 (ko) 2000-10-02 2009-01-30 노보 노르디스크 헬스 케어 악티엔게젤샤프트 비타민 k-의존 단백질의 생산 방법
HUP0402226A2 (hu) * 2001-11-28 2005-02-28 Sandoz Ag. Eljárás sejttenyésztésre
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
PL1902141T3 (pl) 2005-06-17 2012-12-31 Baxalta Inc Kompozycje o działaniu trombolitycznym zawierające ADAMTS13
PL3121266T3 (pl) * 2006-01-04 2020-07-13 Baxalta Incorporated Wolne od oligopeptydów pożywki do hodowli komórkowej
PT2574677T (pt) * 2007-12-27 2017-10-19 Baxalta Inc Processos para cultura de células

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BIOTECHNOLOGY AND BIOENGINEERING, 1995, vol. 48, no. 3, pages 289-300.*
BIOTECHNOLOGY AND BIOENGINEERING,2003, vol. 82, no. 7, pages 751-765.*
JOURNAL OF BIOTECHNOLOGY, 1992, vol. 22, no. 1-2, pages 31-40.*
JOURNAL OF BIOTECHNOLOGY, 1992, vol. 22, no. 1-2, pages 41-50.*

Also Published As

Publication number Publication date
CO6491119A2 (es) 2012-07-31
SG178176A1 (en) 2012-03-29
AU2010277490A1 (en) 2012-02-09
TR201900213T4 (tr) 2019-02-21
US20180051261A1 (en) 2018-02-22
BR112012002137B8 (pt) 2020-05-12
US20140038264A1 (en) 2014-02-06
JP2013500710A (ja) 2013-01-10
EA201270213A1 (ru) 2012-06-29
US8580554B2 (en) 2013-11-12
KR20170077286A (ko) 2017-07-05
US10221400B2 (en) 2019-03-05
PT2459697T (pt) 2019-01-21
US20190153400A1 (en) 2019-05-23
AU2010277490B2 (en) 2014-08-28
JP5808742B2 (ja) 2015-11-10
CN102549142A (zh) 2012-07-04
KR20120038531A (ko) 2012-04-23
WO2011012725A1 (en) 2011-02-03
ES2705206T3 (es) 2019-03-22
HRP20182165T1 (hr) 2019-03-08
JP2015062436A (ja) 2015-04-09
PL2459697T3 (pl) 2019-04-30
KR101752789B1 (ko) 2017-06-30
CA2769354A1 (en) 2011-02-03
EP3480292A1 (en) 2019-05-08
US20110086411A1 (en) 2011-04-14
EA022219B1 (ru) 2015-11-30
CN102549142B (zh) 2014-07-16
WO2011012725A8 (en) 2011-05-05
SI2459697T1 (sl) 2019-03-29
IN2012DN00899A (enExample) 2015-04-03
MX2012001274A (es) 2012-06-01
BR112012002137A2 (pt) 2015-09-15
NZ597742A (en) 2014-02-28
EP2459697A1 (en) 2012-06-06
BR112012002137B1 (pt) 2020-04-14
JP6177260B2 (ja) 2017-08-09
US10745672B2 (en) 2020-08-18
MX353610B (es) 2018-01-18
DK2459697T3 (en) 2019-01-28
EP2459697B1 (en) 2018-10-17
US9650612B2 (en) 2017-05-16

Similar Documents

Publication Publication Date Title
KR101885046B1 (ko) 연속 세포 배양에서 목적 폴리펩티드 또는 바이러스를 생산하는 방법
KR101143796B1 (ko) 개선된 세포 배양 방법
CN111454877B (zh) 一种cho细胞培养方法
CN100348718C (zh) 一种支持hek293细胞贴附培养的无动物来源成分无血清培养基
Thyden et al. Recycling spent animal cell culture media using the thermally resistant microalga Chlorella sorokiniana
JP2859679B2 (ja) 新規細胞株
Hong et al. Development of an alternating tangential flow (ATF) perfusion‐based transient gene expression (TGE) bioprocess for universal influenza vaccine
HK40008436A (en) Method of producing a polypeptide or virus of interest in a continuous cell culture
Zhang Approaches to optimizing animal cell culture process: substrate metabolism regulation and protein expression improvement
Lu et al. Cultivation of immobilized Dictyostelium discoideum for the production of soluble human Fas ligand
HK1169439B (en) Method of producing a polypeptide or virus of interest in a continuous cell culture
HK1169439A (en) Method of producing a polypeptide or virus of interest in a continuous cell culture
CN118667752A (zh) 一种用于生产人骨形态发生蛋白的细胞培养方法
Rodríguez et al. Experimental factorial design for the study of some variables in roller bottles cell culture
HK1137192A (en) Improved process for the culturing of cells

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20170626

Application number text: 1020127004996

Filing date: 20120227

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170913

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20180528

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20180727

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20180727

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20210628

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20220627

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20240625

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20250630

Start annual number: 8

End annual number: 8